PBH · NYSE
Prestige Consumer Healthcare Inc.
$47.80 +1.55 (+3.23%)
Company overview
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates through two segments: North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Exchange
- NYSE
- Market cap
- $2.3B
- Employees
- 600
- Headquarters
- Tarrytown, NY
- Website
- prestigebrands.com
- CEO
- Ronald Lombardi
- Listed
- February 10, 2005
- P/E
- 12.13
- Dividend yield
- 1.25%
Company financials
- Revenue
- $1.1B
- Gross profit
- $587M
- Operating income
- $309M
- EBITDA
- $330M
- Net income
- $190M
- EPS
- $3.94
- Total assets
- $3.5B
- Total debt
- $1B
- Gross margin
- 53.96%
- Net margin
- 17.48%
- Earnings yield
- 8.24%
Showing FY 2026
PBH
1D
NYSE
O48.92H48.96L47.71C47.81-1.65 (-3.34%)Vol152.67K